Toho Acetylene Co., Ltd.

TSE:4093.T

347 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 35,423.72534,087.63731,285.75329,826.0133,561.4136,564.98537,237.64237,613.18733,325.91235,371.68837,996.58135,380.93735,549.38232,089.53231,027.7735,965.76739,903.476
Cost of Revenue 24,249.07823,966.24821,685.82320,380.95323,550.69626,264.64826,951.29527,061.05723,216.38525,391.44128,246.85925,885.49425,891.59622,577.82721,510.21726,033.49529,701.076
Gross Profit 11,174.64710,121.3899,599.939,445.05710,010.71410,300.33710,286.34710,552.1310,109.5279,980.2479,749.7229,495.4439,657.7869,511.7059,517.5539,932.27210,202.4
Gross Profit Ratio 0.3150.2970.3070.3170.2980.2820.2760.2810.3030.2820.2570.2680.2720.2960.3070.2760.256
Reseach & Development Expenses 36.254404336363638.67354.87572.25272746800000
General & Administrative Expenses 7,740.9327,3317,1897,1427,3427,4767,280.6277,222.5817,087.6386,9406,1826,28400000
Selling & Marketing Expenses 1,3021,2681,1821,1131,1451,1611,1571,1311,2271,3461,2641,24300000
SG&A 9,042.9328,5998,3718,2558,4878,6378,437.6278,353.5818,314.6388,2867,4467,52700000
Other Expenses 213.583173.311135.16106.322111.518118.643108.254122.877165.757172.636171.385226.286239.352293.455260.102257.684272.08
Operating Expenses 9,079.1868,599.3298,371.738,255.6118,487.5698,637.1298,476.38,408.4568,386.8898,286.1848,226.3548,319.8538,277.4638,276.7578,360.2799,041.9468,939.888
Operating Income 2,095.4611,522.0591,228.1981,189.4441,523.1441,663.2071,810.0462,143.6731,722.6371,694.0621,523.3671,175.5891,380.3231,234.9471,157.272890.3251,262.511
Operating Income Ratio 0.0590.0450.0390.040.0450.0450.0490.0570.0520.0480.040.0330.0390.0380.0370.0250.032
Total Other Income Expenses Net 278.24716416950269875.48779.3513.202114.861246.737489.869-62.389-472.125-188.374-248.692-355.814
Income Before Tax 2,373.7081,687.6211,398.7581,241.021,550.1381,763.0531,885.5342,223.0251,725.841,808.9241,770.1051,665.4591,317.934762.823968.9641.634906.698
Income Before Tax Ratio 0.0670.050.0450.0420.0460.0480.0510.0590.0520.0510.0470.0470.0370.0240.0310.0180.023
Income Tax Expense 823.551572.762490.807446.447540.624562.292608.659727.176579.661681.209694.79561.829548.438364.376295.719275.79390.725
Net Income 1,415.675988.725823.624738.162923.2881,101.971,167.6741,335.7721,056.9511,028.397979.558972.775654.187315.462587.255271.821504.289
Net Income Ratio 0.040.0290.0260.0250.0280.030.0310.0360.0320.0290.0260.0270.0180.010.0190.0080.013
EPS 40.7428.4823.7521.1526.43157.74167.14191.19151.28147.19140.2139.293.645.1584.0538.972.3
EPS Diluted 40.7428.4823.7521.1526.43157.74167.14191.19151.28147.19140.2139.293.645.1584.0538.972.3
EBITDA 2,760.6162,346.1912,001.261,942.5142,290.0982,555.7552,769.1353,177.9722,818.562,745.9892,613.0092,511.9012,618.1362,406.32,409.6582,139.3552,395.519
EBITDA Ratio 0.0780.0690.0640.0650.0680.070.0740.0840.0850.0780.0690.0710.0740.0750.0780.0590.06